Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

T Cell Activation Regulates CD6 Alternative Splicing by Transcription Dynamics and SRSF1.
The temporal dynamics of visual processing in multiple sclerosis.
Point prevalence and correlates of depression in a national community sample with multiple sclerosis.
Iron deposition in the precentral grey matter in patients with multiple sclerosis: A quantitative study using susceptibility-weighted imaging.
Structure-Kinetics Relationships - an overlooked parameter in hit-to-lead optimization: a case of cyclopentylamines as CCR2 antagonists.
Ischemic skin necrosis caused by glatiramer acetate in multiple sclerosis patients.
Chemokine receptor expression of T cells in the cerebrospinal fluid of relapsing multiple sclerosis.
The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: Interleukin-17A and interleukin-17F serum levels.
S-Allylmercapto-N-acetylcysteine (ASSNAC) protects cultured nerve cells from oxidative stress and attenuates experimental autoimmune encephalomyelitis.
Seropositive Neuromyelitis Optica imitating an Intramedullary Cervical Spinal Cord Tumor: Case Report and Brief Review of the Literature.
Development of a nanomaterial bio-screening platform for neurological applications.
Functional organization of an Mbp enhancer exposes striking transcriptional regulatory diversity within myelinating glia.
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis.
Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis.
The clinical relevance of force platform measures in multiple sclerosis: a review.
A qualitative review of the neurophysiological underpinnings of fatigue in multiple sclerosis.
NMDA receptor antibodies associated with distinct white matter syndromes.
Multiple sclerosis-like lesions and type I interferon signature in a patient with RVCL.
Soluble CD146 in cerebrospinal fluid of active multiple sclerosis.
The switch between relapse and remission in multiple sclerosis: Continuous inflammatory response balanced by Th1 suppression and neurotrophic factors.
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica.
Patient perspectives on physician conflict of interest in industry-sponsored clinical trials for multiple sclerosis therapeutics.
Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients.
The human papillomavirus vaccination is not associated with risk of multiple sclerosis or other demyelinating diseases.
n-3 PUFAs Reduce T-Helper 17 Differentiation by Decreasing Responsiveness to Interleukin-6 in Isolated Splenic Mouse CD4+ T Cells.

Pages